| Year |
Citation |
Score |
| 2023 |
Difede J, McAleavey AA, Emrich M, Jick A, Ovalles A, Wyka K, Spielman L, Olden M, Peskin M, Becket-Davenport C, Rubenstein A, Brownstein MJ, Damiano E, Itzkowitz D, Lu SF, et al. A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment. Contemporary Clinical Trials Communications. 33: 101116. PMID 37008794 DOI: 10.1016/j.conctc.2023.101116 |
0.533 |
|
| 2019 |
Morrison TR, Kulkarni P, Cai X, Iriah S, Aggarwal D, Lu SF, Simon NG, Madularu D, Ferris CF. Treating Head Injury using a Novel Vasopressin 1a Receptor Antagonist. Neuroscience Letters. 134565. PMID 31639422 DOI: 10.1016/J.Neulet.2019.134565 |
0.63 |
|
| 2013 |
Lee RJ, Coccaro EF, Cremers H, McCarron R, Lu SF, Brownstein MJ, Simon NG. A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study. Frontiers in Systems Neuroscience. 7: 100. PMID 24376401 DOI: 10.3389/Fnsys.2013.00100 |
0.632 |
|
| 2013 |
Fabio KM, Guillon CD, Lu SF, Heindel ND, Brownstein MJ, Lacey CJ, Garippa C, Simon NG. Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonist. Journal of Pharmaceutical Sciences. 102: 2033-43. PMID 23471831 DOI: 10.1002/Jps.23495 |
0.62 |
|
| 2012 |
Fabio K, Guillon C, Lacey CJ, Lu SF, Heindel ND, Ferris CF, Placzek M, Jones G, Brownstein MJ, Simon NG. Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging. Bioorganic & Medicinal Chemistry. 20: 1337-45. PMID 22249122 DOI: 10.1016/J.Bmc.2011.12.013 |
0.623 |
|
| 2009 |
Mo Q, Lu S, Garippa C, Brownstein MJ, Simon NG. Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus. The Journal of Steroid Biochemistry and Molecular Biology. 114: 135-43. PMID 19429443 DOI: 10.1016/J.Jsbmb.2009.01.015 |
0.715 |
|
| 2008 |
Simon NG, Guillon C, Fabio K, Heindel ND, Lu SF, Miller M, Ferris CF, Brownstein MJ, Garripa C, Koppel GA. Vasopressin antagonists as anxiolytics and antidepressants: recent developments. Recent Patents On Cns Drug Discovery. 3: 77-93. PMID 18537767 DOI: 10.2174/157488908784534586 |
0.599 |
|
| 2007 |
Guillon CD, Koppel GA, Brownstein MJ, Chaney MO, Ferris CF, Lu SF, Fabio KM, Miller MJ, Heindel ND, Hunden DC, Cooper RD, Kaldor SW, Skelton JJ, Dressman BA, Clay MP, et al. Azetidinones as vasopressin V1a antagonists. Bioorganic & Medicinal Chemistry. 15: 2054-80. PMID 17234419 DOI: 10.1016/J.Bmc.2006.12.031 |
0.653 |
|
| 2006 |
Simon NG, Mo Q, Hu S, Garippa C, Lu SF. Hormonal pathways regulating intermale and interfemale aggression. International Review of Neurobiology. 73: 99-123. PMID 16737902 DOI: 10.1016/S0074-7742(06)73003-3 |
0.69 |
|
| 2006 |
Mo Q, Lu SF, Simon NG. Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity. The Journal of Steroid Biochemistry and Molecular Biology. 99: 50-8. PMID 16524719 DOI: 10.1016/J.Jsbmb.2005.11.011 |
0.708 |
|
| 2006 |
Ferris CF, Lu SF, Messenger T, Guillon CD, Heindel N, Miller M, Koppel G, Robert Bruns F, Simon NG. Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behavior. Pharmacology, Biochemistry, and Behavior. 83: 169-74. PMID 16504276 DOI: 10.1016/J.Pbb.2006.01.001 |
0.675 |
|
| 2005 |
Hu S, Lu SF, Kaplan JR, Adams MR, Simon NG. ERbeta protein expression in female cynomolgus monkey and CF-1 mouse brain: Western analysis. Journal of Neurobiology. 64: 298-309. PMID 15898060 DOI: 10.1002/Neu.20139 |
0.627 |
|
| 2005 |
Simon NG, Lu SF. Androgens and Aggression Biology of Aggression. DOI: 10.1093/acprof:oso/9780195168761.003.0009 |
0.571 |
|
| 2004 |
Mo Q, Lu SF, Hu S, Simon NG. DHEA and DHEA sulfate differentially regulate neural androgen receptor and its transcriptional activity. Brain Research. Molecular Brain Research. 126: 165-72. PMID 15249140 DOI: 10.1016/J.Molbrainres.2004.05.001 |
0.728 |
|
| 2003 |
Lu SF, Mo Q, Hu S, Garippa C, Simon NG. Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity. Journal of Neurobiology. 57: 163-71. PMID 14556282 DOI: 10.1002/Neu.10260 |
0.735 |
|
| 1999 |
Lu S, Simon NG, Wang Y, Hu S. Neural androgen receptor regulation: Effects of androgen and antiandrogen Journal of Neurobiology. 41: 505-512. PMID 10590174 DOI: 10.1002/(Sici)1097-4695(199912)41:4<505::Aid-Neu6>3.0.Co;2-N |
0.687 |
|
| 1998 |
Cologer-Clifford A, Simon NG, Richter ML, Smoluk SA, Lu S. Androgens and estrogens modulate 5-HT(1A) and 5-HT(1B) agonist effects on aggression Physiology and Behavior. 65: 823-828. PMID 10073487 DOI: 10.1016/S0031-9384(98)00240-6 |
0.612 |
|
| 1998 |
Simon NG, Cologer-Clifford A, Lu SF, McKenna SE, Hu S. Testosterone and its metabolites modulate 5HT1A and 5HT1B agonist effects on intermale aggression. Neuroscience and Biobehavioral Reviews. 23: 325-36. PMID 9884126 DOI: 10.1016/S0149-7634(98)00034-7 |
0.69 |
|
| 1998 |
Lu SF, McKenna SE, Cologer-Clifford A, Nau EA, Simon NG. Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology. 139: 1594-601. PMID 9528939 DOI: 10.1210/Endo.139.4.5863 |
0.672 |
|
| 1997 |
Cologer-Clifford A, Simon NG, Lu SF, Smoluk SA. Serotonin agonist-induced decreases in intermale aggression are dependent on brain region and receptor subtype. Pharmacology, Biochemistry, and Behavior. 58: 425-30. PMID 9300602 DOI: 10.1016/S0091-3057(97)00295-5 |
0.681 |
|
| 1996 |
Simon NG, McKenna SE, Lu SF, Cologer-Clifford A. Development and expression of hormonal systems regulating aggression. Annals of the New York Academy of Sciences. 794: 8-17. PMID 8853588 DOI: 10.1111/J.1749-6632.1996.Tb32505.X |
0.663 |
|
| Show low-probability matches. |